galena biopharma inc (GALE:NASDAQ CM)
Gabriel N. Hortobagyi M.D., F.A.C.P.
Member of Scientific Advisory Board,Galena Biopharma, Inc.
|Age||Total Calculated Compensation||This person is connected to 37 board members in 4 different organizations across 5 different industries.|
See Board Relationships
Dr. Gabriel N. Hortobagyi, M.D., F.A.C.P. is a Professor of Medicine, Chairman of the Department of Breast Medical Oncology and Nellie B. Connally Chair in Breast Cancer at the University of Texas M.D. Anderson Cancer Center (MDACC). Dr. Hortobagyi joined MDACC as a Medical Oncology Fellow in 1974 As a member of the M.D. Anderson faculty since 1976, he has been instrumental in developing combination chemotherapy for previously inoperable breast tumors and for improving ...
4640 SW Macadam AvenuePhone: 855-855-4253
Portland, Oregon 97239
Fax: 503- 400-6611
Board Members Memberships*There is no Board Members Memberships data available.
Unknown/Other Education 1970
Universidad Nacional de Colombia
Case Western Reserve University Hospital
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ali Mortazavi||Chief Executive (leave of absence) and Director|
Silence Therapeutics plc
|Mark A. Sirgo Pharm.D.||Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee|
BioDelivery Sciences International, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Arbutus Biopharma Corporation
|Paul C. Grint M.D.||Chief Executive Officer, President and Director|
Regulus Therapeutics Inc.
|Douglas M. Fambrough III, Ph.D.||Co-Founder, Chief Executive Officer, President and Director|
Dicerna Pharmaceuticals, Inc.
|$430.0K||Compensation as of Fiscal Year 2014.|